❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ News archive ❭

Institute seminar February 27th Guro Elisabeth Lind

The Institute Seminar on Wednesday February 27th will ble held by Guro Elisabeth Lind from Section of Cancer Prevention.
Title of her talk: ”Epigenetic biomarkers in cancer – their functional and clinical importance”.

Time and place: 12 - 13 in the Auditorium, New Research Building, Montebello

Links:

Guro E. Lind's group: Epigenetics

Guro E. Lind's publications

Section of Cancer Prevention

Insitute seminars, spring season 2013

 
Scroll to top

Home Cancer Medicine Institute for Cancer Research

  • Dept. of Cancer Genetics
  • Dept. of Cancer Immunology
  • Dept. of Molecular Cell Biology
  • Dept. of Molecular Oncology
  • Dept. of Radiation Biology
  • Dept. of Tumor Biology
  • Dept. of Core Facilities
  • Institute employees
  • Dept./group overview
  • Publications
  • Institute administration
  • Annual reports
  • Institute seminars
  • Vacant positions
  • News archive
  • Scientific Advisory Board
  • ehåndbok/HES procedures

Recent publications

From major journals, first or last author from the Institute for Cancer Research

Teles-Reis J, Rusten TE (2026)
Tumour-host interactions in Drosophila: mechanisms in the tumour micro- and macroenvironment
Mol Oncol (in press)
DOI 10.1002/1878-0261.70207, PubMed 41546533

Zhang X, Johannessen B, Kidd SG, Bogaard M, Stranger A, Axcrona U, Axcrona K, Skotheim RI (2026)
Cell type composition in bulk prostate cancer tissue is a prognostic biomarker
Neoplasia, 72, 101272 (in press)
DOI 10.1016/j.neo.2026.101272, PubMed 41534468

Choudhury SR, Gupta I, Mills I, Mukhina V, Loginov A, Allor E, Anderson A, Cellini A, Robles C, Dyalram D, Lubek J, Wolf J, Taylor R, Hatten K, Vorobyeva N, Gaykalova DA (2026)
HOXC6 overexpression stimulates cell migration and correlates with poor prognosis in head and neck squamous cell carcinoma
Cell Mol Life Sci (in press)
DOI 10.1007/s00018-025-06039-3, PubMed 41521225

More selected publications

Most recent publications

Teles-Reis J, Rusten TE (2026)
Tumour-host interactions in Drosophila: mechanisms in the tumour micro- and macroenvironment
Mol Oncol (in press)
DOI 10.1002/1878-0261.70207, PubMed 41546533

Ianevski A, Nader K, Nguyen J, Sorger H, Timonen S, Julia E, Pölöske D, Spirk K, Wagner C, Jungherz D, Nakano M, Kadambat Nair S, Ianevski P, Kankainen M, Dias D, Cichońska A, Pemovska T, Pirker C, Berger W, Braun T, Moriggl R, Bachy E, Mustjoki S, Herling M, Neubauer HA et al. (2026)
Multiomics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic Discovery
Cancer Res, 86 (2), 295-309
DOI 10.1158/0008-5472.CAN-25-0881, PubMed 41166698

Moura DS, Lopez-Marti J, Tawbi H, Keung E, Wani K, Lazar A, Wang WL, Ingram DR, Meza-Zepeda LA, Myklebost O, Burgess M, Mondaza-Hernandez JL, Hindi N, Martín-Broto J (2026)
Validation of a seven-gene predictive SIGNature for the efficacy of Immuno-Oncology PD-1 inhibitors in patients with Sarcoma (SIGNIOS)
Clin Cancer Res (in press)
DOI 10.1158/1078-0432.CCR-25-2580, PubMed 41537707

More publications

Annual summary of publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)